While deaths from breast cancer may be avoided by screening, any benefit will be more than outweighed by deaths due to the long-term adverse effects of treatment according to Michael Baum, professor emeritus of surgery at University College London.
While deaths from breast cancer may be avoided by screening, any benefit will be more than outweighed by deaths due to the long-term adverse effects of treatment according to Michael Baum, professor emeritus of surgery at University College London.
Writing in the BMJ, he reported that for every 10,000 women invited for screening, three to four breast cancer deaths are avoided at the cost of 2.72 to 9.25 deaths from the long-term toxicity of radiotherapy,
These figures contrast with an independent report on breast cancer screening, led by Sir Michael Marmot published last